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Introduction
Animal welfare mandates adequate analgesia in sepsis
models (Lilley E, Shock 2015; 43: 304). However, it is
unclear which regimen is best to achieve this without
interfering excessively with the scientific experiments. Nal-
buphin, a non-controlled kappa opioid receptor agonist,
has a short half live and a wide therapeutic range and
might therefore be a useful analgesic for research animals.
Objectives
We test the efficacy and safety of intravenous nalbuphin in
our rat model of fecal peritonitis. Here, we report its
respiratory and hemodynamic effects in short-term experi-
ments performed in non-septic rats during anaesthesia.
Methods
In this randomized, placebo-controlled, blinded study,
spontaneously breathing male Wistar rats were anesthe-
tized with isoflurane 3% (air flow 400 ml/min, FiO2 21%).
Nalbuphin (or placebo) was injected subcutaneously at a
dose of 1 mg/kg. After local anaesthesia with lidocaine, the
left carotid artery and the right jugular vein were surgically
cannulated. The isoflurane concentration was reduced to
2%. Intravenous nalbuphin (or placebo) was administered
at two different doses (1 and 5 mg/kg/h). Nalbuphin con-
centration was measured in heparinised plasma by HPLC.
Results are given as mean (standard error of the mean),




Our results demonstrate that high-dose nalbuphin
depresses respiratory rate, heart rate and mean arterial
pressure in anesthetised rats. In order to investigate if the
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Table 1 Results.
Placebo (n=6) Nalbuphin 1 mg/kg/h (n=6) p-value Placebo (n=6) Nalbuphin 5 mg/kg iv (n=6) p-value
Nalbuphin concentration [mg/l] 22.9 (3.7)
Respiratory parameters
Respiration rate [1/min] 55 (3) 45 (2) 0.02 53 (4) 41 (2) 0.04
pO2 [kPa] 9.31 (0.41) 7.86 (0.98) 0.41 10.1 (0.66) 6.81 (0.36) 0.02
SaO2 [%] 92.7 (1.2) 83.9 (3.3) 0.09 93.6 (1.3) 78 (2.7) 0.02
pCO2 [kPa] 6.25 (0.31) 7.72 (0.52) 0.03 6.45 (0.53) 8.49 (0.39) 0.01
Hemodynamic parameters
Heart rate (1/min) 409 (10) 336 (12) 0.00 413 (14) 332 (16) 0.01
Mean arterial pressure (mmHg) 95 (6) 78 (4) 0.04 92 (5) 70 (3) 0.01
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continuous intravenous infusion of nalbuphin influences
our long-term sepsis model, further placebo-controlled
studies in awake septic and non-septic rats are ongoing.
Authors’ details
1University Hospital Zurich, Institute of Anesthesiology, Zurich, Switzerland.
2University Hospital Zurich, Division of Surgical Research, Zurich, Switzerland.
3University Hospital Zurich, Institute for Clinical Chemistry, Zurich,
Switzerland.
Published: 1 October 2015
Reference
1. Lilley E: Shock 2015, 43:304.
doi:10.1186/2197-425X-3-S1-A640
Cite this article as: Hauffe et al.: Respiratory and hemodynamic effects
of intravenous nalbuphin in anesthetized rats. Intensive Care Medicine
Experimental 2015 3(Suppl 1):A640.
Submit your manuscript to a 
journal and benefi t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the fi eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Hauffe et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A640
http://www.icm-experimental.com/content/3/S1/A640
Page 2 of 2
